{"schema_version":"secwatch.filing_event.v1","accession":"0001641489-23-000079","form_type":"8-K","ticker":"VTVT","cik":"0001641489","company_name":"vTv Therapeutics Inc.","filed_at":"2023-11-20T23:59:59+00:00","discovered_at":"2026-05-14T18:03:29.911802+00:00","generated_at":"2026-06-07T23:24:12.901184+00:00","sec_items":["8.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"vTv Therapeutics executes 1-for-40 reverse stock split to regain Nasdaq $1.00 minimum bid compliance","bullets":["Reverse split at 1-for-40 ratio became effective at 4:01 p.m. ET on November 20, 2023.","Purpose is to regain compliance with Nasdaq's $1.00 minimum closing price for continued listing.","Fractional shares resulting from the split are rounded up to the nearest whole share.","Percentage ownership unchanged for each stockholder except for fractional share adjustments.","Class A common stock continues trading under symbol VTVT with new CUSIP 91835204."],"urls":{"canonical":"https://secwatch.observer/filing/0001641489-23-000079","json":"https://secwatch.observer/filing/0001641489-23-000079.json","markdown":"https://secwatch.observer/filing/0001641489-23-000079.md","text":"https://secwatch.observer/filing/0001641489-23-000079.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1641489/000164148923000079/0001641489-23-000079-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1641489/000164148923000079/vtvt-20231120.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-07T23:24:12.901184+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}